Literature DB >> 16225360

Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option?

Stefan Wirz1, Eberhard Klaschik.   

Abstract

This study assessed the efficacy of laxative use for treatment of constipation in patients receiving opioid therapy, with special attention to polyethylene glycol 3350/electrolyte solution (PEG-ES). Computerized data from 206 patients were analyzed using descriptive statistics. Subgroups were analyzed using confirmatory statistics. Constipation occurred in 42.7 percent of patients. Laxatives were administered to 74.3 percent of these patients using a standardized step scheme, with good results in 78.4 percent. As a therapy for constipation, the combined administration of PEG-ES, sodium picosulphate, and liquid paraffin proved most effective, although statistical analysis yielded no significance. Early use of PEG-ES using a step scheme holds promise for treatment of opioid-related constipation in palliative care patients, although further investigation is warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225360     DOI: 10.1177/104990910502200511

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  10 in total

1.  Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database.

Authors:  Lars Morten Skollerud; Olav Ms Fredheim; Kristian Svendsen; Svetlana Skurtveit; Petter C Borchgrevink
Journal:  Support Care Cancer       Date:  2012-06-01       Impact factor: 3.603

2.  Clinical use of oral laxatives in palliative care services in Spain.

Authors:  Antonio Noguera; Carlos Centeno; Silvia Librada; María Nabal
Journal:  Support Care Cancer       Date:  2010-08-08       Impact factor: 3.603

Review 3.  [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].

Authors:  S Bader; M Weber; G Becker
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

4.  PEG vs. sennosides for opioid-induced constipation in cancer care.

Authors:  Philippa Hawley; Hannah MacKenzie; Monica Gobbo
Journal:  Support Care Cancer       Date:  2019-07-18       Impact factor: 3.603

Review 5.  [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].

Authors:  Jürgen Osterbrink; Ute Haas
Journal:  Wien Med Wochenschr       Date:  2008

6.  Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.

Authors:  Peter Deibert; Carola Xander; Hubert E Blum; Gerhild Becker
Journal:  Core Evid       Date:  2010-06-15

Review 7.  [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].

Authors:  D Chappell; P Conzen
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

Review 8.  Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Clin Exp Gastroenterol       Date:  2014-09-19

9.  Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board.

Authors:  Marco Rossi; Giuseppe Casale; Danilo Badiali; Federica Aielli; Maria Antonietta Aloe Spiriti; Roberto Arcioni; Francesca Bordin; Maurizio Ferrara; Gloria Morelli Sbarra; Antonio Corcione; Franco Marinangeli; Paolo Marchetti
Journal:  Support Care Cancer       Date:  2019-02-18       Impact factor: 3.603

10.  The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: A Prospective Observational Study.

Authors:  Suratsawadee Wangnamthip; Skaorat Panchoowong; Carolina Donado; Kimberly Lobo; Pimporn Phankhongsap; Pinyo Sriveerachai; Pramote Euasobhon; Pranee Rushatamukayanunt; Sahatsa Mandee; Nantthasorn Zinboonyahgoon; Charles B Berde
Journal:  Pain Res Manag       Date:  2021-07-20       Impact factor: 3.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.